A whole-animal platform to advance a clinical kinase inhibitor into new disease spaceMasahiro Sonoshita, Arvin C. Dar, Alexander M. Real et al.|Nature Chemical Biology|2018Cited by 73
Integrated computational and Drosophila cancer model platform captures previously unappreciated chemicals perturbing a kinase networkPeter M.U. Ung, Avner Schlessinger, Masahiro Sonoshita et al.|PLoS Computational Biology|2019Cited by 13
Integrated computational and <i>Drosophila</i> cancer model platform captures previously unappreciated chemicals perturbing a kinase networkPeter M.U. Ung, Avner Schlessinger, Ross Cagan et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 1
Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancerTakako Ooshio, Masahiro Sonoshita|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1